The Burden of Alzheimer's: Cost, Controversy, and Integrity

This chapter explores the economic and emotional toll of Alzheimer's disease, projecting care costs to hit $1 trillion by 2050. It critically examines the effectiveness and controversies surrounding recent treatment options, particularly targeting beta amyloid, revealing significant concerns about data manipulation in research. Furthermore, it emphasizes the importance of integrity in scientific studies and investor accountability in the face of potential fraud.